
    
      This study is a phase 1b clinical trial to investigate the safety and preliminary effects of
      a single dose of a test drug or placebo to the subjects who has diagnosed as COVID-19
      infection.

      Study design: prospective, randomized, placebo-controlled, single-blind, single-center
    
  